Advertisement

The Latest

In May, Holyoke (Mass.) Medical Center became one of 10 hospitals selected in Massachusetts to participate in an initiative, dubbed the Healthy Work Environment Academy, that aims to empower frontline nurses to lead workplace culture and retention efforts. “Nurses are…

“First, do no harm” may be the most well-known adage in the medical profession, but it’s far more than an admonishment. Preventing harm by investing in patient safety is a smart business strategy that returns incalculable direct and indirect financial…

President Donald Trump demanded that pharmaceutical companies release data for “success rates” of their COVID-19 medications to clear up what he called a “discrepancy mess.”  In a Sept. 1 Truth Social post, President Trump said he had been shown “extraordinary”…

The University of Maryland Baltimore Washington Medical Center has named Jeffrey Marshall, MD, vice president and associate chief medical officer — a role in which he will be responsible for quality, safety and regulatory compliance in both inpatient and ambulatory…

More than 1 in 5 medical students in the U.S. experience food insecurity, pointing to the need for institution and policy-level interventions to support basic student needs, according to a new study led by researchers at New Haven, Conn.-based Yale…

In the face of ongoing supply disruptions and increasing pressures, Sutter Health has turned to a NASA-inspired approach called Tiger Teams.  Tiger Teams were first implemented by the California-based health system in 2020 during the peak of the COVID-19 pandemic;…

Cincinnati-based TriHealth has completed the acquisition of Clinton Memorial Hospital, a 140-bed facility in Wilmington, Ohio, marking its sixth acute care hospital. The facility will be renamed TriHealth Clinton Regional Hospital and serve as a hub for the system’s specialized…

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine.  The study’s findings are based on data from…

Both semaglutide and tirzepatide were shown to “significantly reduce” the risk of hospitalization and all-cause mortality for heart failure patients, according to a study published Aug. 31 in JAMA.  Researchers from Somerville, Mass.-based Mass General Brigham analyzed U.S. insurance claim…

Advertisement